ask="2.12"
ask_size="700"
average_daily_volume="48238"
bid="N/A"
bid_size="N/A"
book_value="0.81"
change="-0.19"
change_from_200_day_moving_average="0.06"
change_from_50_day_moving_average="0.07"
change_from_52_week_high="-1.91"
change_From_52_week_low="0.55"
change_in_percent="-9.69%"
close="1.77"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.26"
ebitda="-6.98M"
eps_estimate_current_year="-0.16"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.48"
ex_dividend_date="N/A"
float_shares="2843000"
high="1.96"
high_52_weeks="3.68"
last_trade_date="2/22/2017"
last_trade_price="1.77"
last_trade_size="100"
last_trade_time="3:58pm"
low="1.71"
low_52_weeks="1.22"
market_capitalization="19.45M"
moving_average_200_day="1.71"
moving_average_50_day="1.70"
name="Cleveland BioLabs
Inc."
notes="N/A"
one_year_target_price="2.00"
open="1.96"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+3.64%"
percent_change_from_50_day_moving_average="+4.08%"
percent_change_from_52_week_high="-51.90%"
percent_change_from_52_week_low="+45.08%"
previous_close="1.96"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.42"
price_per_sales="5.67"
revenue="3.80M"
shares_outstanding="10987000"
short_ratio="0.62"
stock_exchange="NCM"
symbol="CBLI"
volume="39336"
weeks_range_52="1.22 - 3.68"
